跳至主要内容
临床试验/IRCT20181207041873N3
IRCT20181207041873N3尚未招募未知

Comparison of the effect of vaginal misoprostol and evening primrose oil capsules with misoprostol alone on the consequences of abortion in women with intrauterine fetal death

Iran University of Medical Sciences0 个研究点目标入组 84 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • Iranian nationality
  • Older and equal to 18 years
  • Gestational age 12 to 20 weeks
  • Having a single fetus according to ultrasound confirmation
  • Initial bishop score less than four
  • BMI less than 30
  • Indication of termination of pregnancy due to intrauterine death of the fetus with confirmation two ultrasounds

排除标准

  • Drugs abuse
  • smoking more than ten cigarettes a day
  • History of cesarean section
  • Contraindications to the use of evening primrose include: history of mental illness with phenothiazine, history of epilepsy, schizophrenia, history of bleeding disorders and use of anticoagulants
  • Medical disorders in the mother such as heart disease, lung disease, active liver disease, acute hepatitis
  • Previously known drug allergies to misoprostol include drowsiness, tremors, seizures, shortness of breath, hypotension, and bradycardia (WWW.Drugs.com)
  • Medicinal allergies to evening primrose, including urticaria, wheezing, facial edema, lips, tongue and throat (WWW.Drugs.com)
  • Severe anemia
  • Having cervical anomalies
  • Evening capsule vaginal capsule for two weeks continuous
  • Severe vaginal bleeding
  • Having a history of unsuccessful pregnancy
  • History of using any herbal and chemical drugs to help abortion before admission
  • Contraindications to misoprostol use include: ectopic pregnancy, use of estrodiol-free drugs, symptoms of pelvic infection or sepsis, unstable hemodynamic status, mitral stenosis, glaucoma, asthma, bronchitis

研究者

相似试验